General MedicationsORALGeneric
NORLUTATE
NORETHINDRONE ACETATE
Standard Dose
5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview NORLUTATE is listed in Drugs@FDA under application 012184 (NDA).
Marketing status: Discontinued Active ingredient NORETHINDRONE ACETATE Form and strength TABLET;ORAL - 5MG Sponsor PARKE DAVIS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview NORLUTATE is listed in Drugs@FDA under application 012184 (NDA). Marketing status: Discontinued Active ingredient NORETHINDRONE ACETATE Form and strength TABLET;ORAL - 5MG Sponsor PARKE DAVIS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.